Pune: City hospital to check efficacy of ultra-short TB preventive therapy on people with HIV

The study ‘One to Three’ will compare the treatment completion of daily dose of Rifapentine and Isoniazid for a month (1HP) to the weekly dose of Rifapentine and Isoniazid for three months (3HP) in persons living with HIV in Pune.

Related Keywords

India ,Pune ,Maharashtra ,Vidya Mave ,Neetal Nevrekar ,Nishi Suryavanshi ,Vinayak Kale ,Rohidas Borse ,Bj Government Medical College ,Clinical Research Site ,World Health Organisation ,Johns Hopkins University ,Research Site ,Anti Retroviral Therapy ,Johns Hopkins ,Tuberculosis Pune ,Uberculosis New Study India ,Ivcases India ,Uberculosis India ,India Tb ,Tuberculosis News ,Une News ,